Akande, Oluwatosin WuraolaIgumbor, Ehimario UcheElimian, Kelly Osezele2022-08-162022-08-162022Akande, O. W. et al. (2022). Covid-19 vaccine effectiveness studies in Nigeria: Quo vadis?. Journal of global health, 12, 03055. 10.7189/jogh.12.030552047-298610.7189/jogh.12.03055http://hdl.handle.net/10566/7735The “lickety-split” development of COVID-19 vaccines 326 days from when the SARS-COV-2 virus was first sequenced is indeed one of the public health successes of the 21st century. Particularly because an 18-month target was initially considered reasonable, and having achieved this success, a “moonshot” goal to ensure that a vaccine is available within 100 days after the next pandemic pathogen is recognized has been set [1].enCovid-19Public healthVaccineNigeriaWorld Health Organisation (WHO)Article